FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Mutations in the fused in sarcoma (FUS) gene are linked to neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).
• The FUS p.P525L variant is a common mutation associated with ALS, often presenting with atypical symptoms beyond typical motor neuron degeneration.
• Movement disorders associated with the FUS p.P525L mutation require further emphasis in clinical understanding.

Purpose of the Study:

• To investigate the clinical presentation and genetic basis of amyotrophic lateral sclerosis (ALS) in patients with the FUS p.P525L mutation.
• To highlight the association between the FUS p.P525L mutation and diverse movement disorders in ALS patients.
• To explore potential therapeutic targets by examining muscle pathology in affected individuals.

Main Methods:

• Clinical and laboratory evaluation of two unrelated ALS patients.
• Next-generation sequencing for genetic screening of FUS mutations.
• Histological and immunohistochemical analysis of muscle biopsies.

Main Results:

• Both patients were diagnosed with ALS and carried a de novo FUS p.P525L mutation.
• Patient 1 exhibited juvenile-onset weakness, dropped head, ophthalmoplegia, tremor, involuntary movements, and cognitive issues.
• Patient 2 presented with typical ALS symptoms and significant adventitious movements; muscle biopsies revealed neurogenic patterns and lipid droplets.

Conclusions:

• The FUS p.P525L mutation can lead to significant clinical heterogeneity in ALS, including various movement disorders.
• The presence of lipid droplets in muscle fibers suggests skeletal muscle as a potential therapeutic target for ALS.
• Further research is warranted to fully understand the spectrum of FUS-related ALS and develop targeted treatments.